Topoisomerase Inhibitor class drugs

6 results

  • etopophos

    (etoposide phosphate)
    H2-Pharma, LLC
    ETOPOPHOS is indicated for use in combination with other chemotherapeutic agents to treat refractory testicular tumors and, alongside cisplatin, for the first-line treatment of small cell lung cancer.
    Medication Details
    Drug Interactions

  • etoposide

    (Etoposide)
    Meitheal Pharmaceuticals Inc.
    Etoposide Injection is indicated for managing refractory testicular tumors and as a first-line treatment for small cell lung cancer, used in combination with other approved chemotherapy agents following appropriate surgical and therapeutic interventions.
    Medication Details
    Drug Interactions

  • irinotecan hydrochloride

    (Irinotecan Hydrochloride)
    Ingenus Pharmaceuticals, LLC
    Irinotecan hydrochloride injection is indicated for first-line therapy, in combination with 5-fluorouracil and leucovorin, for metastatic colon or rectum carcinoma. It is also used for patients whose disease has recurred or progressed after initial fluorouracil-based therapy.
    Medication Details
    Drug Interactions

  • onivyde

    (IRINOTECAN HYDROCHLORIDE)
    Ipsen Biopharmaceuticals, Inc.
    ONIVYDE is indicated for use in combination with other medications for treating metastatic pancreatic adenocarcinoma in adults, both as a first-line treatment and after progression on gemcitabine-based therapy. It is not approved as a standalone treatment for this condition.
    Medication Details
    Drug Interactions

  • topotecan

    (Topotecan)
    Accord Healthcare Inc.
    Topotecan Injection is indicated for treating sensitive small cell lung cancer after first-line chemotherapy failure and, in combination with cisplatin, for stage IV-B, recurrent, or persistent cervical carcinoma not suitable for curative surgery or radiation therapy.
    Medication Details
    Drug Interactions

  • topotecan hydrochloride

    (TOPOTECAN HYDROCHLORIDE)
    Fresenius Kabi USA, LLC
    Topotecan hydrochloride is indicated for treating metastatic ovarian cancer after chemotherapy progression, small cell lung cancer in platinum-sensitive patients post-first-line treatment progression, and Stage IV-B cervical cancer in combination with cisplatin, for patients not eligible for curative treatment.
    Medication Details
    Drug Interactions